insights_auto
Why is GOVX down 5.97%?
Dive Deeperchevron_right
GOVX:NASDAQ
Geovax Labs Inc
$0.23
arrow_downward
-5.97%(-0.014) 1D
Oct 15, 12:29:03 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GOVX...
Open
$0.24
High
$0.25
Low
$0.23
Mkt. cap
2.03M
Avg. vol.
732.63K
Volume
401.72K
52-wk high
$15.75
52-wk low
$0.23
EPS
-$13.92
Beta
3.69
Shares outstanding
10.10M
No. of employees
19
Open
$0.24
High
$0.25
Low
$0.23
Mkt. cap
2.03M
Avg. vol.
732.63K
Volume
401.72K
52-wk high
$15.75
52-wk low
$0.23
EPS
-$13.92
Beta
3.69
Shares outstanding
10.10M
No. of employees
19
News stories
From web sources and news partners
The Olympian
·
16 minutes ago
Nasdaq reports network disruption, US equities data feeds impacted
TradingView
·
1 hour ago
TruGolf Holdings (NASDAQ: TRUG) Taps Newly Acquired Polymath to Tokenize Franchise Ownership Records
Yahoo Finance
·
1 hour ago
Dr. Calvin Choi on TGE's NYSE Listing and Global SPAC Strategy
Seeking Alpha
·
26 minutes ago
Midday Markets Need to Know: Ukraine flags Starlink curbs, Fed rate hike odds fall, and more (SP500:)
Profile
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia
About Geovax Labs Inc
CEODavid A. Dodd
Employees19
Founded1988
HeadquartersAtlanta, Georgia, United States
SectorBiotechnology
Websitegeovax.com